Open Study Summaries – Colorectal Cancers

Please consult with your physician or contact the cancer research office at 757-388-2840.

Rectal Cancer

Alliance N1048 – A Phase II/III Trial of Neoadjuvant FOLFOX with Selective Use of Combined Modality Chemoradiation versus Preoperative Combined Modality Chemoradiation for Locally Advanced Rectal Cancer Patients Undergoing Low Anterior Resection with Total Mesorectal Excision. (PROSPECT)

GI002 – A Phase II Clinical Trial Platform of Sensitization Utilizing Total Neoadjuvant Therapy (TNT) in Rectal Cancer

{{moduleTitle}}